🇺🇸 AMPH — Amphastar Pharmaceuticals, Inc.

Salud Mantener
← Volver

Precio actual

27,12 USD

Máx. histórico

65,00

1183 días

Caída desde máximo

-58,28%

Rango 52 semanas

16,65 – 29,52

Variación hoy

+0,33%

Cierre anterior

27,03

Rango de hoy

26,85 – 27,39

Volumen hoy

550.210

Peor caída histórica

-74,05%

08/08/2023 → 15/05/2026

Aún sin recuperar

Volatilidad anualizada ⓘ

42,87%

Información
Nombre completo
Amphastar Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
1.976
PER ⓘ
16,05 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
22,50 USD (puede no estar actualizado)
Primera cotización
25/06/2014
Precio actualizado
hace 20 horas
Sobre la empresa

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; and emergency syringe products, including atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate. In addition, it offers Albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm; Iron sucrose injection, an iron replacement product for the treatment of iron deficiency anemia in patients with chronic kidney disease; Teriparatide injection for managing daily osteoporosis therapy; and Ipratropium Bromide HFA inhalation aerosol, an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease. Further, the company provides active pharmaceutical ingredient (API) products, such as Recombinant Human Insulin and porcine insulin API. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/03/2019 20,55 20,80 20,12 20,23 -1,32% 3,31% 663.700
14/03/2019 20,64 20,70 19,70 20,50 -0,87% 4,84% 398.400
13/03/2019 21,50 22,54 20,35 20,68 -14,44% 10,19% 1.099.000
12/03/2019 23,74 24,40 23,61 24,17 +1,90% 3,33% 140.500
11/03/2019 23,79 24,01 23,39 23,72 -0,38% 2,61% 191.700
08/03/2019 23,70 24,00 23,65 23,81 -0,08% 1,48% 117.900
07/03/2019 24,10 24,44 23,71 23,83 -1,41% 3,03% 196.900
06/03/2019 24,77 24,77 24,05 24,17 -2,26% 2,91% 161.100
05/03/2019 24,76 25,13 24,40 24,73 +0,00% 2,95% 100.500
04/03/2019 25,32 25,43 24,63 24,73 -2,18% 3,16% 255.600
01/03/2019 24,95 25,34 24,66 25,28 +1,73% 2,73% 355.700
28/02/2019 24,38 24,90 24,38 24,85 +1,39% 2,13% 263.500
27/02/2019 24,14 24,59 23,96 24,51 +1,36% 2,61% 160.800
26/02/2019 23,78 24,32 23,73 24,18 +1,17% 2,48% 390.700
25/02/2019 24,14 24,26 23,80 23,90 -0,99% 1,91% 163.200
22/02/2019 23,93 24,29 23,76 24,14 -0,21% 2,21% 159.400
21/02/2019 24,57 24,62 24,08 24,19 -1,71% 2,20% 104.600
20/02/2019 24,29 24,63 24,11 24,61 +1,23% 2,14% 244.300
19/02/2019 24,40 24,49 24,04 24,31 -0,29% 1,84% 104.900
15/02/2019 23,86 24,47 23,65 24,38 +2,22% 3,44% 197.800
14/02/2019 23,86 24,19 23,83 23,85 +0,08% 1,51% 170.400
13/02/2019 23,80 23,91 23,68 23,83 -0,13% 0,97% 71.400
12/02/2019 23,38 23,87 23,21 23,86 +2,18% 2,82% 263.900
11/02/2019 23,08 23,35 22,80 23,35 +1,70% 2,38% 114.700
08/02/2019 22,66 23,10 22,66 22,96 +0,39% 1,94% 117.500
07/02/2019 22,90 23,07 22,65 22,87 -0,39% 1,83% 73.900
06/02/2019 23,13 23,38 22,84 22,96 -0,82% 2,33% 99.900
05/02/2019 22,86 23,40 22,86 23,15 +1,58% 2,36% 164.600
04/02/2019 22,56 22,79 22,26 22,79 +1,29% 2,35% 142.600
01/02/2019 22,72 22,85 22,39 22,50 -1,14% 2,02% 100.000